{"id":4302,"date":"2017-08-12T11:10:18","date_gmt":"2017-08-12T11:10:18","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/2017\/08\/12\/clinical-and-translational-oncology-feasibility-of-a-deep-hyperthermia-and-radiotherapy-programme-for-advanced-tumors-first-spanish-experience\/"},"modified":"2025-09-03T08:33:26","modified_gmt":"2025-09-03T08:33:26","slug":"klinisk-provning-hypertermi-cancer","status":"publish","type":"post","link":"https:\/\/andromedichyperthermia.com\/sv\/klinisk-provning-hypertermi-cancer\/","title":{"rendered":"Klinisk pr\u00f6vning: Prelimin\u00e4ra resultat av kemoradioterapi plus hypertermi och h\u00f6gdoserad brachyterapi f\u00f6r lokalt avancerad cervixcancer"},"content":{"rendered":"<div><\/div>\n<div class=\"clinical_trial\">\n<h1 style=\"text-align: center;\"><a href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/POSTER-HT-ESHO-2014-clarke.pdf\"><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">Klinisk pr\u00f6vning: Prelimin\u00e4ra resultat av kemoradioterapi plus hypertermi och h\u00f6gdoserad brachyterapi f\u00f6r lokalt avancerad cervixcancer<\/span><\/span><\/a><\/h1>\n<h2 style=\"text-align: center;\"><a href=\"https:\/\/www.esho.info\/\" target=\"_blank\" rel=\"noopener\"><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">Klinisk pr\u00f6vning av andromedisk hypertermi &#8211; European Society for Hyperthermic Oncology kongress 2014\u00a0<\/span><\/span><\/a><\/h2>\n<h2 style=\"text-align: center;\"><\/h2>\n<figure id=\"attachment_114\" aria-describedby=\"caption-attachment-114\" style=\"width: 590px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-114 size-full\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" alt=\"Klinisk pr\u00f6vning - Prelimin\u00e4ra resultat av kemoradioterapi plus andromedisk hypertermi och h\u00f6gdoserad brachyterapi f\u00f6r lokalt avancerad cervixcancer\" width=\"590\" height=\"837\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg 590w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-211x300.jpg 211w\" sizes=\"auto, (max-width: 590px) 100vw, 590px\" \/><figcaption id=\"caption-attachment-114\" class=\"wp-caption-text\"><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">Prelimin\u00e4ra resultat av kemoradioterapi plus andromedisk hypertermi och h\u00f6gdoserad brachyterapi f\u00f6r lokalt avancerad cervixcancer<\/span><\/span><\/figcaption><\/figure>\n<p><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">E. Clarke, V. De Sanctis, C. Scaringi, M. Valeriani, MF Osti, R. Maurizi Enrici Sant&#8217;Andrea Hospital, Radiotherapy Dept, University of Rome &#8217;Sapienza&#8217;, Rom. Italien<\/span><\/span><\/p>\n<p><strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">M\u00c5L<\/span><\/span><\/strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\"> Att unders\u00f6ka resultatet av kemoradioterapi plus hypertermi (HT) och h\u00f6gdosbrachyterapi (BRT) f\u00f6r lokalt avancerad cervixcancer (LACC). Huruvida kemoradioterapi anses vara standardbehandling vid LACC. Till\u00e4gg av HT till enbart str\u00e5lbehandling (RT) har visat sig f\u00f6rb\u00e4ttra lokal tum\u00f6rkontroll och total \u00f6verlevnad utan att p\u00e5verka behandlingsrelaterad akut eller sen toxicitet av grad 3 till 4 hos denna patientgrupp.<\/span><\/span><\/p>\n<p><strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">MATERIAL OCH METODER<\/span><\/span><\/strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\"> Fr\u00e5n januari 2013 till december 2013 deltog 8 patienter med LACC eller lokalt \u00e5terkommande cervixcancer (LRCC) efter hysterektomi (3 stadium IIB, I IIIB, 2 NEI respektive 3 LRCC) i en pilotstudie som kombinerade veckovis cisplatin och HT med intensitetsmodulerad str\u00e5lbehandling (IMRT) f\u00f6ljt av BRT. En dos p\u00e5 50,4 Gy till b\u00e4ckenlymfk\u00f6rtlarna med samtidig integrerad boost (SIB) av den brutto tum\u00f6rvolymen (GTV) till totalt 61,8 Gy i 28 fraktioner administrerades inom 5,5 veckor. BRT-dosen var 21 Gy i 3 fraktioner. Samtidig kemoterapibehandling bestod av veckovis cisplatin 4\/mg\/m2 och HT administrerades en g\u00e5ng i veckan.<\/span><\/span><\/p>\n<p><strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">RESULTAT Alla patienter uppn\u00e5dde lokal kontroll. En patient upplevde \u00e5terfall utanf\u00f6r b\u00e4ckenet med multipel ben- och paraaortal nodal involvering. Ingen behandlingsrelaterad akut eller sen grad 3 till 4 toxicitet observerades.<\/span><\/span><\/strong><\/p>\n<p><strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">SLUTSATSER Denna behandling tolererades v\u00e4l med ett gott kliniskt svar. Till\u00e4gg av HT till kemoradioterapi representerar en lovande ny strategi.<\/span><\/span><\/strong><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\"> Multiinstitutionella samarbeten och l\u00e4ngre uppf\u00f6ljning beh\u00f6vs f\u00f6r att bekr\u00e4fta dess effekt.<\/span><\/span><\/p>\n<p><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">BIBLIOGRAFI<\/span><\/span><\/p>\n<p><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">1. Lutgens L. van der Zee J. Pijls-Johannesma M, De Haas-Kock DF, Buijsen J. Mastrigt GA. Lammering G. De Ruysscher DK. Lambin R Kombinerad anv\u00e4ndning av hypertermi och str\u00e5lbehandling f\u00f6r behandling av lokalt avancerad livmoderhalscancer. Cochrane Database Syst Rev. 2010 17 mars:(3):CD008377. doi:10.1002\/14851858.CD006377.pub3.<\/span><\/span><\/p>\n<p><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">2. van der Zee J. Gonzalez Gonzalez D. van Rhoon GC, van Dijk JD. van Pullen WL, Hart AA. J\u00e4mf\u00f6relse av enbart str\u00e5lbehandling med str\u00e5lbehandling plus hypertermi vid lokalt avancerade b\u00e4ckentum\u00f6rer: en prospektiv, randomiserad, multicenterstudie. Dutch Deep Hyperthemba Group. Lancet. 2000 1 april:355(9210):1119-25.<\/span><\/span><\/p>\n<p><span dir=\"auto\" style=\"vertical-align: inherit;\"><span dir=\"auto\" style=\"vertical-align: inherit;\">3. Green J, Kirwan .1, Tremey J. Vale C. Symonds R Fresco L. Williams C. Collingwood M. Samtidig kemoterapi och str\u00e5lbehandling f\u00f6r livmoderhalscancer. Cochrane Database Syst Rev. 2005 Jul 20;(3):C0002225.<\/span><\/span><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Klinisk pr\u00f6vning: Prelimin\u00e4ra resultat av kemoradioterapi plus hypertermi och h\u00f6gdoserad brachyterapi f\u00f6r lokalt avancerad cervixcancer Klinisk pr\u00f6vning av andromedisk hypertermi &#8211; European Society for Hyperthermic Oncology kongress 2014\u00a0 E. Clarke, V. De Sanctis, C. Scaringi, M. Valeriani, MF Osti, R. Maurizi Enrici Sant&#8217;Andrea Hospital, Radiotherapy Dept, University of Rome &#8217;Sapienza&#8217;, Rom. Italien M\u00c5L Att unders\u00f6ka&hellip;<\/p>\n","protected":false},"author":1,"featured_media":7031,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[190],"tags":[222,351,223,224,225,226],"class_list":["post-4302","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-sv","tag-advanced-tumors-sv","tag-hypertermi-sv","tag-hyperthermia-sv","tag-local-hyperthermia-sv","tag-meht-sv","tag-radiotherapy-sv"],"gutentor_comment":1,"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/posts\/4302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/comments?post=4302"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/posts\/4302\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/media\/7031"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/media?parent=4302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/categories?post=4302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/tags?post=4302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}